Browsing by Author Bradstock, Kenneth

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 110  next >
Issue DateTitleAuthor(s)Citation
2007Activated circulating dendritic cells after hematopoietic stem cell transplantation predict acute graft-versus-host diseaseBradstock, Kenneth; Lau, Justine; Sartor, M; Hart, Derek N J; Munster, David J; Vuckovic, Slavica; Western Clinical School: Westmead Millennium Institute; School of Medical Sciences: Pharmacology; Western Clinical School: Medicine (Westmead)Activated circulating dendritic cells after hematopoietic stem cell transplantation predict acute graft-versus-host disease, Transplantation 2005, vol.83,(7),2007,pp 839-846
2007Activation of Wnt/beta-catenin pathway mediates growth and survival in B-cell progenitor acute lymphoblastic leukaemiaBendall, Linda; Bradstock, Kenneth; Khan, Naveed; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium InstituteActivation of Wnt/beta-catenin pathway mediates growth and survival in B-cell progenitor acute lymphoblastic leukaemia, British Journal of Haematology, vol.138,(3),2007,pp 338-348
2012All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4)Bradstock, Kenneth; Hertzberg, Mark; Iland, Harry; Browett, Peter; Catalano, Alberto; Collins, Marnie; Dilulio, J.; et al, various; Firkin, Frank; Grigg, Andrew P.; Hugman, Amanda; Reynolds, John; Supple, Shane; Tiley, Campbell; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead); Central Clinical School: MedicineAll-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4), Blood, vol.120, 8, 2012,pp 1570-1580
2011Allogeneic hematopoietic cell transplant for multiple myeloma using reduced intensity conditioning therapy, 1998-2006: factors associated with improved survival outcomeBradstock, Kenneth; Gibson, John; Simpson, Judith; Bradstock, Kenneth F.; Dodds, A. J.; Doocey, Richard; Ganly, Peter; Ma, David D. F.; Nivison-Smith, Ian; Szer, Jeff; Western Clinical School: Westmead Millennium Institute; Central Clinical School: Medicine; School of Public Health: Public HealthAllogeneic hematopoietic cell transplant for multiple myeloma using reduced intensity conditioning therapy, 1998-2006: factors associated with improved survival outcome, Leukemia and Lymphoma, vol.52, 9, 2011,pp 1727-1735
2012Allogeneic Hematopoietic Cell Transplantation for Chronic Myelofibrosis in Australia and New Zealand: Older Recipients Receiving Myeloablative Conditioning at Increased Mortality RiskBradstock, Kenneth; Simpson, Judith; Butler, Jason; Dodds, Anthony J; Ma, David; Nivison-Smith, Ian; Szer, Jeff; Western Clinical School: Westmead Millennium Institute; School of Public Health: Public HealthAllogeneic Hematopoietic Cell Transplantation for Chronic Myelofibrosis in Australia and New Zealand: Older Recipients Receiving Myeloablative Conditioning at Increased Mortality Risk, Biology of Blood and Marrow Transplantation, vol.18, 2, 2012,pp 302-308
2006Allogeneic stem cell transplantation with peripheral blood stem cells mobilized by pegylated G-CSF.Bradstock, Kenneth; Butler, Jason; Durrant, Simon; Fuery, Madonna; Grigg, Andrew P.; Hill, Geoffrey R.; Hutchins, Cheryl; Kennedy, Gregor; Morris, Edward S.; Morton, James; Roberts, Andrew; Szer, Jeffrey; Western Clinical School: Westmead Millennium InstituteAllogeneic stem cell transplantation with peripheral blood stem cells mobilized by pegylated G-CSF., Biology Of Blood And Marrow Transplantation, vol.12,(6),2006,pp 603-607
2013Alterations in Chemokine Receptor CCR5 Expression on Blood Dendritic Cells Correlate With Acute Graft-Versus-Host DiseaseBradstock, Kenneth; Hart, Derek; Sartor, Mary; Shahin, Kifah; Western Clinical School: Westmead Millennium Institute; Concord Clinical School: ANZAC Research InstituteAlterations in Chemokine Receptor CCR5 Expression on Blood Dendritic Cells Correlate With Acute Graft-Versus-Host Disease, Transplantation, vol.96, 8, 2013,pp 753-762
2016The Analysis of CD83 Expression on Human Immune Cells Identifies a Unique CD83+-Activated T Cell PopulationBradstock, Kenneth; Bryant, Christian; Clark, Georgina; Fromm, Phillip; Gibson, John; Hart, Derek; Hsu, Jennifer; Hsu, Weihsun; Larsen, Stephen; Lee, Kenneth; Li, Ziduo; Lo, Tsunho; Silveira, Pablo; Alingcastre, Renz; Clarke, Candice; De, Barbarafazekas; Elgundi, Zehra; Ju, Xinsheng; Kupresanin, Fiona; McGuire, Helen; Verma, Nirupama; Western Clinical School: Westmead Institute for Medical Res; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research Institute; Central Clinical School: Medicine; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research Institute; Central Clinical School: Medicine; Concord Clinical School: Medicine; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research InstituteThe Analysis of CD83 Expression on Human Immune Cells Identifies a Unique CD83+-Activated T Cell Population, The Journal of Immunology, vol.197, 12, 2016,pp 4613-4625
2006Analysis of human leukaemias and lymphomas using extensive immunophenotypes from an antibody microarray.Barber, Nicole; Belov, Larissa; Bendall, Linda; Bradstock, Kenneth; Christopherson, Richard; Mulligan, Stephen; Sartor, M; Wiley, James; Young, Graham; Chrisp, Jeremy S; Erber, Wendy; Green, Anthony R; Huang, Pauline; Juneja, Surender; Keating, Michael J; Pascovici, Dana S; Scott, Mike A; Sewell, William A; Stoner, Kerryn; Thomas, Mervyn; Wierda, William G; Woolfson, Adrian; Molecular & Microbial Bioscien; Molecular & Microbial Bioscien; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Molecular & Microbial Bioscien; Molecular & Microbial Bioscien; Western Clinical School: Medicine (Westmead); Nepean Clinical School: Medicine; Central Clinical School: MedicineAnalysis of human leukaemias and lymphomas using extensive immunophenotypes from an antibody microarray., British Journal of Haematology, vol.135,(2),2006,pp 184-97
2005Androgen receptor gene expression in leucocytes is hormonally regulated: implications for gender differences in disease pathogenesisBradstock, Kenneth; Celermajer, David; Handelsman, David; Heather, Alison; Hill, Michael; Jimenez, Mark; McGrath, Kristine; Sader, Mark; Western Clinical School: Westmead Millennium Institute; Central Clinical School: Medicine; Concord Clinical School: ANZAC Research Institute; Central Clinical School: Medicine; Medicine Faculty Office; Concord Clinical School: Medicine; Central Clinical School: Medicine; Medicine Faculty OfficeAndrogen receptor gene expression in leucocytes is hormonally regulated: implications for gender differences in disease pathogenesis, Clinical Endocrinology (2005), vol.62,(1),2005,pp 56-63
2014Antibody therapy for acute myeloid leukaemiaBradstock, Kenneth; Clark, Georgina; Gasiorowski, Robin Edward; Hart, Derek; Western Clinical School: Westmead Millennium Institute; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research InstituteAntibody therapy for acute myeloid leukaemia, British Journal of Haematology, vol.164, 4, 2014,pp 481-495
2006Autologous stem cell transplantation in adults with acute lymphoblastic leukemia in first complete remission: analysis of the LALA-85,-87 and-94 trials.Bradstock, Kenneth; Boiron, Jean-Michel; Dhedin, N.; Dombret, Hervé; et, al; Kuentz, M.; Lheritier, V.; Reman, O.; Rigal-Huguet, F.; Thomas, Xavier; Vernant, J-P; Western Clinical School: Westmead Millennium InstituteAutologous stem cell transplantation in adults with acute lymphoblastic leukemia in first complete remission: analysis of the LALA-85,-87 and-94 trials., Leukemia, vol.20,(2),2006,pp 336-344
2017Bone Marrow Graft-Versus-Host Disease in Major Histocompatibility Complex-Matched Murine Reduced-Intensity Allogeneic Hemopoietic Cell TransplantationBendall, Linda; Bradstock, Kenneth; Hart, Derek; Mattar, Zamil; Shahin, Kifah; Silveira, Pablo; Hsu, Wei-Hsun; Westmead Clinical School: Westmead Institute for Medical Res; Westmead Clinical School: Westmead Institute for Medical Res; Concord Clinical School: ANZAC Research Institute; Medicine; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research InstituteBone Marrow Graft-Versus-Host Disease in Major Histocompatibility Complex-Matched Murine Reduced-Intensity Allogeneic Hemopoietic Cell Transplantation, Transplantation, vol.101, 11, 2017,pp 2695-2704
2002Cancer cell-associated fibronectin induces release of matrix metalloproteinase-2 from normal fibroblastsBendall, Linda; Bradstock, Kenneth; Gottlieb, David; Overall, Christopher M.; Saad, Sonia; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium InstituteCancer cell-associated fibronectin induces release of matrix metalloproteinase-2 from normal fibroblasts, Cancer Research, vol.62,(N/A),2002,pp 283-289
2016A CD2 high-expressing stress-resistant human plasmacytoid dendritic-cell subsetBradstock, Kenneth; Bryant, Christian; Clark, Georgina; Fromm, Phillip; Hart, Derek; Ho, Joy Phoebe; Joshua, Douglas; Lee, Kenneth; Silveira, Pablo; Brown, Ross D.; Clarke, Candice; Cunningham, Ilona; Gibson, John; Kupresanin, Fiona; Newman, Elizabeth; Suen, Hayley; Western Clinical School: Westmead Institute for Medical Res; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research Institute; Central Clinical School: Medicine; Central Clinical School: Medicine; Concord Clinical School: Medicine; Concord Clinical School: ANZAC Research InstituteA CD2 high-expressing stress-resistant human plasmacytoid dendritic-cell subset, Immunology and Cell Biology, vol.94, 5, 2016,pp 447-457
2016A CD2 high-expressing stress-resistant human plasmacytoid dendritic-cell subsetBradstock, Kenneth; Bryant, Christian; Clark, Georgina; Fromm, Phillip; Hart, Derek; Ho, Joy Phoebe; Joshua, Douglas; Lee, Kenneth; Silveira, Pablo; Brown, Ross D.; Clarke, Candice; Cunningham, Ilona; Gibson, John; Kupresanin, Fiona; Newman, Elizabeth; Suen, Hayley; Western Clinical School: Westmead Institute for Medical Res; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research Institute; Central Clinical School: Medicine; Central Clinical School: Medicine; Concord Clinical School: Medicine; Concord Clinical School: ANZAC Research InstituteA CD2 high-expressing stress-resistant human plasmacytoid dendritic-cell subset, Immunology and Cell Biology, vol.94, 5, 2016,pp 447-457
2011Cellular therapy to treat haematological and other malignancies: progress and pitfallsBradstock, Kenneth; Gottlieb, David; Hart, Derek; Frommer, P. D.; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Concord Clinical School: ANZAC Research InstituteCellular therapy to treat haematological and other malignancies: progress and pitfalls, Pathology, vol.43, 6, 2011,pp 605-615
2004Chemokines And Their Receptors As Therapeutic Targets: The Role Of The Sdf-1/Cxcr4 Axis.Bendall, Linda; Bradstock, Kenneth; Juarez, Julius; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead)Chemokines And Their Receptors As Therapeutic Targets: The Role Of The Sdf-1/Cxcr4 Axis., Current Pharmaceutical Design, vol.10,(11),2004,pp 1245-1259
2016CMRF-56+ blood dendritic cells loaded with mRNA induce effective antigen-specific cytotoxic T-lymphocyte responsesBradstock, Kenneth; Bryant, Christian; Clark, Georgina; Fromm, Phillip; Hart, Derek; Ho Lo, Tsun; Horvath, Lisa; Joshua, Douglas; Papadimitrious, Michael Stephen; Silveira, Pablo; Van Kooten Losio, Nicolas; Verma, Nirupama; Anguille, Sebastien; Barnard, Ross; et al, Various; Hsu, Jennifer; Mahler, Stephen; Munster, David; Nagasakid, Tomoko; Prue, R; Turtle, Cameron; Vukovic, Peter; Western Clinical School: Westmead Institute for Medical Res; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research Institute; Central Clinical School: Medicine; Central Clinical School: Medicine; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research InstituteCMRF-56+ blood dendritic cells loaded with mRNA induce effective antigen-specific cytotoxic T-lymphocyte responses, OncoImmunology, vol.5, 6, 2016,pp 1-12
2012Combination Strategies for Stem Cell Mobilization Targeting CXCR4 and S1P ReceptorsBendall, Linda; Bradstock, Kenneth; Harun, Nadia; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead)Combination Strategies for Stem Cell Mobilization Targeting CXCR4 and S1P Receptors in Novel Developments in Stem Cell Mobilization, Springer Science + Business Media, 2012, pp. 37-54